Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ARES✓SelectedUSD · ARESMRNA vs ARES performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs ARES

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+149.2%
ARES return
+31.0%
Excess return
+118.3%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioARESExcessAlpha
1D-4.8%+0.2%-5.0%-4.9%
7D-20.9%-7.2%-13.7%-18.1%
30D-13.3%+13.3%-26.5%-17.9%
3M+212.6%-7.8%+220.4%+226.4%
6M+309.0%+5.6%+303.4%+304.1%
YTD+567.3%-18.1%+585.4%+613.7%
1Y+689.7%-6.6%+696.3%+700.5%
All+149.2%+31.0%+118.3%+142.5%

Cumulative growth

Daily Returns

Daily percentage return beside ARES.

Daily Out/Under-Performance

Portfolio return minus ARES return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ARES return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ARES wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling